Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
60%
COVID-19
21%
Immunocompromised Patient
20%
Coinfection
20%
Monoclonal Antibody Therapy
20%
Molecular Epidemiology
20%
Bacteriophage
20%
Serum (Blood)
20%
Staphylococcus Aureus
20%
Microcalorimetry
20%
Monoclonal Antibody
13%
Viral Clearance
10%
Lineages
10%
Omicron Coronavirus Variant
8%
Genome Sequencing
6%
Immune Escape
6%
Spike
6%
Genomic Surveillance
6%
Whole Genome Sequencing
6%
Host Range
6%
Decision Making
6%
Virus Evolution
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
80%
Immunocompromised Patient
20%
Prospective Cohort Study
20%
Monoclonal Antibody Therapy
20%
Molecular Epidemiology
20%
COVID-19
16%
Monoclonal Antibody
13%
Viral Clearance
10%
Monotherapy
6%
Therapeutic Vaccine
6%
Public Health
6%
Host Range
6%
Whole Genome Sequencing
6%
Decision Making
6%
Genome Sequencing
6%
Antigenicity
5%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Monoclonal Antibody
20%
Immunocompromised Patient
20%
Prospective Cohort Study
20%
Viral Clearance
10%
Respiratory Tract Disease
10%
Monotherapy
6%
Infection
5%
Diseases
5%
